Summary
IDEXX LABORATORIES INC. (IDXX) announced a change to its Board of Directors via an 8-K filing on July 18, 2019. The company elected Sam Samad as an independent Class I Director and a member of its Audit Committee, effective July 16, 2019. This appointment involved increasing the Board size from eight to nine directors, with Mr. Samad expected to stand for stockholder election in 2021. His appointment is a standard procedural update and does not involve any related party transactions. Mr. Samad's compensation will align with that of other non-employee directors, with prorated cash fees for the third quarter of 2019 and prorated stock unit and option grants to be issued on September 1, 2019. The company also furnished a press release detailing this board appointment as an exhibit to the filing. This update primarily signals a strengthening of the Board's oversight and governance structure through the addition of an experienced director.
Key Highlights
- 1IDEXX Laboratories elected Sam Samad as an independent Class I Director to its Board.
- 2Mr. Samad has also been appointed as a member of the company's Audit Committee.
- 3The Board size has been increased from eight to nine directors to accommodate the new appointment.
- 4Mr. Samad's election is effective July 16, 2019, and he is expected to be a Class I Director until the 2021 annual meeting.
- 5Compensation for Mr. Samad will be prorated and align with existing non-employee director compensation practices.
- 6No related person transactions were reported concerning Mr. Samad's appointment.
- 7A press release dated July 18, 2019, regarding the appointment is included as an exhibit.